378 related articles for article (PubMed ID: 12704110)
1. Use of the Galleria mellonella caterpillar as a model host to study the role of the type III secretion system in Pseudomonas aeruginosa pathogenesis.
Miyata S; Casey M; Frank DW; Ausubel FM; Drenkard E
Infect Immun; 2003 May; 71(5):2404-13. PubMed ID: 12704110
[TBL] [Abstract][Full Text] [Related]
2. ExoU is a potent intracellular phospholipase.
Sato H; Frank DW
Mol Microbiol; 2004 Sep; 53(5):1279-90. PubMed ID: 15387809
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of type III secretion genes in clinical and environmental isolates of Pseudomonas aeruginosa.
Feltman H; Schulert G; Khan S; Jain M; Peterson L; Hauser AR
Microbiology (Reading); 2001 Oct; 147(Pt 10):2659-2669. PubMed ID: 11577145
[TBL] [Abstract][Full Text] [Related]
4. Alveolar response to Pseudomonas aeruginosa: role of the type III secretion system.
Ader F; Le Berre R; Faure K; Gosset P; Epaulard O; Toussaint B; Polack B; Nowak E; Viget NB; Kipnis E; Guery BP
Infect Immun; 2005 Jul; 73(7):4263-71. PubMed ID: 15972518
[TBL] [Abstract][Full Text] [Related]
5. Relative contributions of Pseudomonas aeruginosa ExoU, ExoS, and ExoT to virulence in the lung.
Shaver CM; Hauser AR
Infect Immun; 2004 Dec; 72(12):6969-77. PubMed ID: 15557619
[TBL] [Abstract][Full Text] [Related]
6. Exoenzyme Y Contributes to End-Organ Dysfunction Caused by
Wagener BM; Anjum N; Christiaans SC; Banks ME; Parker JC; Threet AT; Walker RR; Isbell KD; Moser SA; Stevens T; Alexeyev MF; Audia JP; Richter W; Hardy KS; Saleh LA; Morgan C; Pittet JF
Toxins (Basel); 2020 Jun; 12(6):. PubMed ID: 32512716
[No Abstract] [Full Text] [Related]
7. Influence of virulence genotype and resistance profile in the mortality of Pseudomonas aeruginosa bloodstream infections.
Peña C; Cabot G; Gómez-Zorrilla S; Zamorano L; Ocampo-Sosa A; Murillas J; Almirante B; Pomar V; Aguilar M; Granados A; Calbo E; Rodríguez-Baño J; Rodríguez-López F; Tubau F; Martínez-Martínez L; Oliver A;
Clin Infect Dis; 2015 Feb; 60(4):539-48. PubMed ID: 25378459
[TBL] [Abstract][Full Text] [Related]
8. Contribution of ExsA-regulated factors to corneal infection by cytotoxic and invasive Pseudomonas aeruginosa in a murine scarification model.
Lee EJ; Cowell BA; Evans DJ; Fleiszig SM
Invest Ophthalmol Vis Sci; 2003 Sep; 44(9):3892-8. PubMed ID: 12939306
[TBL] [Abstract][Full Text] [Related]
9. Role of Pseudomonas aeruginosa type III effectors in disease.
Engel J; Balachandran P
Curr Opin Microbiol; 2009 Feb; 12(1):61-6. PubMed ID: 19168385
[TBL] [Abstract][Full Text] [Related]
10. Novel type III effectors in Pseudomonas aeruginosa.
Burstein D; Satanower S; Simovitch M; Belnik Y; Zehavi M; Yerushalmi G; Ben-Aroya S; Pupko T; Banin E
mBio; 2015 Mar; 6(2):e00161. PubMed ID: 25784698
[TBL] [Abstract][Full Text] [Related]
11. Diverse effects of Galleria mellonella infection with entomopathogenic and clinical strains of Pseudomonas aeruginosa.
Andrejko M; Zdybicka-Barabas A; Cytryńska M
J Invertebr Pathol; 2014 Jan; 115():14-25. PubMed ID: 24513029
[TBL] [Abstract][Full Text] [Related]
12. ExoU expression by Pseudomonas aeruginosa correlates with acute cytotoxicity and epithelial injury.
Finck-Barbançon V; Goranson J; Zhu L; Sawa T; Wiener-Kronish JP; Fleiszig SM; Wu C; Mende-Mueller L; Frank DW
Mol Microbiol; 1997 Aug; 25(3):547-57. PubMed ID: 9302017
[TBL] [Abstract][Full Text] [Related]
13. High frequency of the exoU+/exoS+ genotype associated with multidrug-resistant "high-risk clones" of Pseudomonas aeruginosa clinical isolates from Peruvian hospitals.
Horna G; Amaro C; Palacios A; Guerra H; Ruiz J
Sci Rep; 2019 Jul; 9(1):10874. PubMed ID: 31350412
[TBL] [Abstract][Full Text] [Related]
14. Type III secretion-dependent modulation of innate immunity as one of multiple factors regulated by Pseudomonas aeruginosa RetS.
Zolfaghar I; Evans DJ; Ronaghi R; Fleiszig SM
Infect Immun; 2006 Jul; 74(7):3880-9. PubMed ID: 16790760
[TBL] [Abstract][Full Text] [Related]
15. Diverse type III secretion phenotypes among Pseudomonas aeruginosa strains upon infection of murine macrophage-like and endothelial cell lines.
Stepińska M; Trafny EA
Microb Pathog; 2008 May; 44(5):448-58. PubMed ID: 18221854
[TBL] [Abstract][Full Text] [Related]
16. Triggering the ExoS regulon of Pseudomonas aeruginosa: A GFP-reporter analysis of exoenzyme (Exo) S, ExoT and ExoU synthesis.
Hornef MW; Roggenkamp A; Geiger AM; Hogardt M; Jacobi CA; Heesemann J
Microb Pathog; 2000 Dec; 29(6):329-43. PubMed ID: 11095918
[TBL] [Abstract][Full Text] [Related]
17. The molecular mechanism of acute lung injury caused by Pseudomonas aeruginosa: from bacterial pathogenesis to host response.
Sawa T
J Intensive Care; 2014; 2(1):10. PubMed ID: 25520826
[TBL] [Abstract][Full Text] [Related]
18. Identification of virulence genes in a pathogenic strain of Pseudomonas aeruginosa by representational difference analysis.
Choi JY; Sifri CD; Goumnerov BC; Rahme LG; Ausubel FM; Calderwood SB
J Bacteriol; 2002 Feb; 184(4):952-61. PubMed ID: 11807055
[TBL] [Abstract][Full Text] [Related]
19. Positive correlation between virulence of Pseudomonas aeruginosa mutants in mice and insects.
Jander G; Rahme LG; Ausubel FM
J Bacteriol; 2000 Jul; 182(13):3843-5. PubMed ID: 10851003
[TBL] [Abstract][Full Text] [Related]
20. ExoS and ExoT ADP ribosyltransferase activities mediate Pseudomonas aeruginosa keratitis by promoting neutrophil apoptosis and bacterial survival.
Sun Y; Karmakar M; Taylor PR; Rietsch A; Pearlman E
J Immunol; 2012 Feb; 188(4):1884-95. PubMed ID: 22250085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
